Optimization of ex vivo activation and expansion of macaque primary CD4-enriched peripheral blood mononuclear cells for use in anti-HIV immunotherapy and gene therapy strategies

Journal of Acquired Immune Deficiency Syndromes

Volumn 32, Issue 3, 2003, Pages 245-254

  Zhang, Dongsheng ^a   Murakami, Akikazu ^a   Johnson, R Paul ^a   Sui, Jianhua ^a   Cheng, Jihua ^a   Bai, Jirong ^a   Marasco, Wayne A ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Coreceptors; Macaque CD4 T cells; Proliferation; Transduction.

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR5; CONCANAVALIN A; HUMAN IMMUNODEFICIENCY VIRUS 1 TAT INTRABODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD28; MONOCLONAL ANTIBODY CD3; NERVE GROWTH FACTOR RECEPTOR; RETROVIRUS VECTOR; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY HUTAT2; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL TRANSFER; CONTROLLED STUDY; CULTURE MEDIUM; DRUG PROTEIN BINDING; DRUG TARGETING; GENE THERAPY; GENETIC CODE; GENETIC TRANSDUCTION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOTHERAPY; IN VITRO STUDY; IRRADIATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE; MOLONEY LEUKEMIA ONCOVIRUS; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHESUS MONKEY; T LYMPHOCYTE; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; ANTIBODIES; ANTIGENS, CD28; ANTIGENS, CD3; BLOOD TRANSFUSION, AUTOLOGOUS; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; CONCANAVALIN A; CULTURE MEDIA, CONDITIONED; GENE THERAPY; GENETIC VECTORS; HIV INFECTIONS; HIV-1; IMMUNOTHERAPY; LYMPHOCYTE ACTIVATION; MACACA; MOLONEY MURINE LEUKEMIA VIRUS; PHYTOHEMAGGLUTININS; RECEPTORS, CCR5; RECEPTORS, CXCR4; RECOMBINANT FUSION PROTEINS; TIME FACTORS; TRANSDUCTION, GENETIC;

EID: 0037340732     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200303010-00002     Document Type: Article

References (22)

1. Marasco WA. Intracellular antibodies (intrabodies) as research reagents and therapeutic molecules for gene therapy. Immunotechnology 1995;1:1-19.
2. Marasco WA. Intrabodies: turning the humoral immune system outside in for intracellular immunization. Gene Ther 1997;4:11-5.
3. Mhashilkar AM, Bagley J, Chen SY, et al. Inhibition of HIV-1 Tat-mediated LTR transactivation and HIV-1 infection by anti-Tat single chain intrabodies. EMBO J 1995;14:1542-51.
4. Mhashilkar AM, LaVecchio J, Eberhardt B, et al. Inhibition of human immunodeficiency virus type 1 replication in vitro in acutely and persistently infected human CD4+ mononuclear cells expressing murine and humanized anti-human immunodeficiency virus type 1 Tat single-chain variable fragment intrabodies. Hum Gene Ther 1999;10:1453-67.
5. Marasco WA, LaVecchio J, Winkler A. Human anti-HIV-1 tat sFv intrabodies for gene therapy of advanced HIV-1-infection and AIDS. J Immunol Methods 1999;231:223-38.
6. Johnson RP, Glickman RL, Yang JQ, et al. Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus. J Virol 1997;71:7711-8.
7. Verzeletti S, Bonini C. Marktel S, et al. Herpes simplex virus thymidine kinase gene transfer for controlled graft-versus-host disease and graft-versus-leukemia: clinical follow-up and improved new vectors. Hum Gene Ther 1998;9:2243-51.
8. Miller AD, Miller DG, Garcia JV, et al. Use of retroviral vectors for gene transfer and expression. Methods Enzymol 1993;217: 581-99.
9. Zhu Q, Zeng C, Huhalov A, et al. Extended half-life and elevated steady-state level of a single-chain Fv intrabody are critical for specific intracellular retargeting of its antigen, caspase-7. J Immunol Methods 1999;231:207-22.
10. Bunnell BA, Muul LM, Donahue RE, et al. High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes. Proc Natl Acad Sci USA 1995;92: 7739-43.
11. Brodie SK, et al. In vivo migration and function of transferred HIV-1-specific cytotoxic T cells. Nat Med 1999;5:34.
12. Levine BL. Bernstein WB, Connors M, et al. Effects of CD28 costimulation on long-term proliferation of CD4+ T cells in the absence of exogenous feeder cells. J Immunol 1997:159: 5921-30.
13. Brice GT, Riley JL, Villinger F, et al. Development of an animal model for autotransfusion therapy: in vitro characterization and analysis of anti-CD3/CD28 expanded cells. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 19: 210-6.
14. Levine BL. Bernstein WB, Aronson NE, et al. Adoptive transfer of costimulated CD4+ T cells induces expansion of peripheral T cells and decreased CCR5 expression in HIV infection. Nat Med 2002; 8:47-53.
15. Moller G. Hammarstrom L, Moller E, et al. Lymphocyte activation by Con A. Hematologia (Budap) 1978-79; 12:37-45.
16. Sutkowski N, Kuo ML, Amenta PS, et al. A peripheral blood- derived monolayer supports long-term cultures of human CD4+ and CD8+ T lymphocytes. Blood 1995;85:3213-22.
17. Henkart PA, Fisher RI. Characterization of the lymphocyte surface receptors for Con A and PHA. J Immunol 1975:114(Part 1): 710-4.
18. Maus MV, Thomas AK, Leonard DG, et al. Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB. Nat Biotechnol 2002;20:143-8.
19. Barillari G, Buonaguro L, Fiorelli V, et al. Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression: implications for AIDS-Kaposi's sarcoma pathogenesis. J Immunol 1992:149:3727-34.
20. Baggiolini M, Dewald B, Moser B. Human chemokines: an update. Annu Rev Immunol 1997;15:675-705.
21. Bermejo M. Martin-Serrano J, Oberlin E, et al. Activation of blood T lymphocytes downregulates CXCR4 expression and interferes with propagation of X4 HIV strains. Eur J Immunol 1998;28: 3192-204.
22. Signoret N, Oldridge J, Pelchen-Matthews A, et al. Phorbol esters and SDF-1 induce rapid endocytosis and down modulation of the chemokine receptor CXCR4. J Cell Biol 1997;139:651-64.